This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
AT Europe 2017: Roundtable Discussion Notes
Share |

 

Roundtable Sessions

Thank you for attending AT Europe 2017! Below you will find the abstracts and discussion notes from each of the tables.  
Click on the links below the facilitator and scribe names to view a PDF of the notes from that day.


               
 

   Table 1: Emerging Technologies in Protein Characterization, including High Throughput Analysis

   Session 1

    Facilitator: Pierre Allemand, Protein Metrics Inc.
    Scribe: Lars Geurink, Janssen Infectious Diseases and Vaccines
   
To view the table notes, click here.

    Session 2

    Facilitator: Henrik Jensen, University of Copenhagen
    ScribeCari Sänger-van de Griend, Kantisto BV
    To view the table notes, click here.

 

   Table 2: New Trends in Analytical Technologies for Process Control (USP, DSP, fill and finish), Including Analysis of Process Related Impurities

    Session 1

    Facilitator: Harold Taylor, Merz Pharmaceuticals GmbH & Co KGaA
    Scribe: Helén Nyhlén, Genovis AB
 
  To view the table notes, click here.

    Session 2

    FacilitatorLars Geurink, Janssen Infectious Diseases and Vaccines
    ScribeArnaud Delobel, Quality Assistance Ltd.
 
   To view the table notes, click here.

 

   Table 3: Method Lifecycle Management - From Early Development to Method Transfer and Maintenance

    Session 1

    Facilitator: Robert Mayer, Sandoz GmbH
    Scribe: Richard Shannon, MedImmune, A member of the AstraZeneca Group
   
 To view the table notes, click here.

    Session 2

    Facilitator: Markus Wild, F. Hoffmann - La Roche Ltd.
    Scribe: Dietmar Strehlow, Wacker Biotech GmbH
   
 To view the table notes, click here.

 

   Table 4: Role of Analytics in Understanding Critical Quality Attributes

    Session 1

    Facilitator: Anders Lund, Genzyme Corporation, a Sanofi Company
    ScribeCari Sänger - van de Griend, Kantisto B.V.
     
To view the table notes, click here.

    Session 2

    Facilitator: András Guttman, University of Pannonia
    Scribe: Jim Thorn, SCIEX Separations
 
   Notes from this table are unavailable at this time.

 

   Table 5: New Technologies for Analysis of HCPs

    Session 1

    FacilitatorSéverine Clavier, Sanofi
    Scribe: Thomas Flad, Protagen Protein Services GmbH
    
To view the table notes, click here.

    Session 2

    Facilitator: Thomas Flad, Protagen Protein Services GmbH
    ScribeSéverine Clavier, Sanofi
   
 To view the table notes, click here.

   

   Table 6: Analytical Technologies for Formulation Development of Biopharmaceuticals

    Session 1

    FacilitatorChristof Finkler, F. Hoffmann – La Roche Ltd 
    ScribeMarta Germano, Janssen Infectious Diseases and Vaccines
   
Notes from this table are not available at this time.

    Session 2

    FacilitatorHarold Taylor, Merz Pharmaceuticals GmbH
    ScribeAnja Bathke, F. Hoffmann – La Roche Ltd
 
    To view the table notes, click here.

 

   Table 7: HOS Methods - Capabilities and Limitations

    Session 1

    Facilitator: David Keire, CDER, FDA
    Scribe: András Guttman, University of Pannonia
    
To view the table notes, click here.

    Session 2

    Facilitator: Birgit Schmauser, BfArM
    ScribeGábor Járvás,  University of Pannonia
    
To view the table notes, click here.

   

   Table 8: New Trends in MS

    Session 1

    Facilitator: Lisa Marzilli, Pfizer, Inc.
    Scribe: Stephen Lock, SCIEX Separations
     
To view the table notes, click here.

    Session 2

    Facilitator: Hansjörg Toll, Sandoz GmbH
    Scribe: Valentina D'Atri, University of Geneva
 
   To view the table notes, click here.

   

   Table 9: Comparability

    Session 1

    FacilitatorTerry Cyr, Health Canada
    Scribe: Anne Trappe, NIBRT
     
To view the table notes, click here.

    Session 2

    FacilitatorMartin Bluggel, Protagen Protein Services GmbH
    Scribe: Robert Mayer, Sandoz GmbH
   
 To view the table notes, click here.

 

   Table 10: Developments in Analytical Strategies for Bispecifics, ADCs, or New Formats

    Session 1

    Facilitator: Jennifer Rea, Genentech, a Member of the Roche Group
    ScribeVirginie Bettonville, University of Liege
   
To view the table notes, click here.

    Session 2

    FacilitatorJulie Bonvin, F. Hoffmann-La Roche Ltd.
    Scribe: Cédric Delvaux, University of Liege
     
To view the table notes, click here.

    

   Table 11: The Need for Regulatory Guidance on Product Characterization

    Session 1

    FacilitatorMartin Blüggel, Protagen Protein Services GmbH
    ScribeBirgit Schmauser, BfArM
   
 To view the table notes, click here.

    Session 2

    FacilitatorMarta Germano, Janssen Infectious Diseases and Vaccines 
    Scribe: Ashraf Ali, Inha University
   
 To view the table notes, click here.

 

 


 

    


 

 

 

more Calendar

1/28/2019 » 1/31/2019
CMC Strategy Forum and WCBP 2019

1/29/2019 » 1/31/2019
WCBP 2019 Live Stream

3/12/2019 » 3/13/2019
CMC Strategy Forum Latin America 2019

Featured Members
William Weiss, Eli Lilly and CompanyFind out more about Will in this month's Member Spotlight!

Membership Software Powered by YourMembership  ::  Legal